Paying Off Generics To Prevent Competition With Brand Name Drugs PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Paying Off Generics To Prevent Competition With Brand Name Drugs PDF full book. Access full book title Paying Off Generics To Prevent Competition With Brand Name Drugs.
Author | : |
Publisher | : DIANE Publishing |
Total Pages | : 186 |
Release | : |
Genre | : |
ISBN | : 9781422322987 |
Download Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing Book in PDF, ePub and Kindle
Author | : United States. Congress. Senate. Committee on the Judiciary |
Publisher | : |
Total Pages | : 184 |
Release | : 2007 |
Genre | : Business & Economics |
ISBN | : |
Download Paying Off Generics to Prevent Competition with Brand Name Drugs Book in PDF, ePub and Kindle
Author | : United States. Congress. Senate. Committee on the Judiciary |
Publisher | : |
Total Pages | : 180 |
Release | : 2007 |
Genre | : Competition, Unfair |
ISBN | : |
Download Paying Off Generics to Prevent Competition with Brand Name Drugs Book in PDF, ePub and Kindle
Author | : U.S. Government Printing Office (Gpo) |
Publisher | : BiblioGov |
Total Pages | : 188 |
Release | : 2013-10 |
Genre | : |
ISBN | : 9781293028094 |
Download S. Hrg. 110-4 Book in PDF, ePub and Kindle
The United States Government Printing Office (GPO) was created in June 1860, and is an agency of the U.S. federal government based in Washington D.C. The office prints documents produced by and for the federal government, including Congress, the Supreme Court, the Executive Office of the President and other executive departments, and independent agencies. A hearing is a meeting of the Senate, House, joint or certain Government committee that is open to the public so that they can listen in on the opinions of the legislation. Hearings can also be held to explore certain topics or a current issue. It typically takes between two months up to two years to be published. This is one of those hearings.
Author | : Competition P. Subcommittee on Antitrust |
Publisher | : CreateSpace |
Total Pages | : 134 |
Release | : 2015-06-17 |
Genre | : |
ISBN | : 9781514385494 |
Download Pay-For-Delay Deals Book in PDF, ePub and Kindle
In 2012, analysts estimate that Americans spent $325 billion on prescription drugs and they predict that drug sales will rise by more than four percent in the year 2014. Generic drugs, which can cost as much as 90 percent lower than brand-name drugs, help rein in the costs. A brand-name drug that costs $300 per month might be sold as a generic for as little as $30 per month, but for several years, pay-for-delay deals have robbed consumers of cost-saving generic drugs. At the very core, these deals involve collusion between brand and generic competitors to keep generic competition off the market. A brand-name drug company pays their generic competitor cash or another form of payment. In exchange, the generic delays its entry into the marketplace. The brand company wins because it gets to maintain its monopoly, and the generic company wins because they get paid more than they would have if they came to market. But American consumers and American taxpayers lose out on lower-cost generic drugs to the tune of billions of dollars each year, $3.5 billion according to the Federal Trade Commission.
Author | : National Academies of Sciences, Engineering, and Medicine |
Publisher | : National Academies Press |
Total Pages | : 235 |
Release | : 2018-03-01 |
Genre | : Medical |
ISBN | : 0309468086 |
Download Making Medicines Affordable Book in PDF, ePub and Kindle
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author | : |
Publisher | : U.S. Government Printing Office |
Total Pages | : 94 |
Release | : 1998 |
Genre | : Business & Economics |
ISBN | : |
Download How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry Book in PDF, ePub and Kindle
Author | : Christina M. Curtin |
Publisher | : Nova Science Publishers |
Total Pages | : 0 |
Release | : 2011 |
Genre | : Drugs |
ISBN | : 9781611220711 |
Download Generic Drugs Book in PDF, ePub and Kindle
Brand-name pharmaceutical companies can delay generic competition that lowers prices by agreeing to pay a generic competitor to hold its competing product off the market for a certain period of time. These so-called "pay-for-delay" agreements have arisen as part of patent litigation settlement agreements between brand-name and generic pharmaceutical companies. "Pay-for-delay" agreements are "win-win" for the companies: brand name pharmaceutical prices stay high, and the brand and generic share the benefits of the brand's monopoly profits. Consumers lose, however: they miss out on generic prices that can be as much as 90 percent less than brand prices. For example, brand-name medication that costs $300 per month, might be sold as a generic for as little as $30 per month. This book examines the "pay-for-delay' program and how drug company pay-offs cost consumers billions.
Author | : |
Publisher | : DIANE Publishing |
Total Pages | : 129 |
Release | : 2002 |
Genre | : |
ISBN | : 1428951938 |
Download Generic drug entry prior to patent expiration an FTC study Book in PDF, ePub and Kindle
Author | : Robin Feldman |
Publisher | : Cambridge University Press |
Total Pages | : 165 |
Release | : 2017-06-09 |
Genre | : Law |
ISBN | : 131673949X |
Download Drug Wars Book in PDF, ePub and Kindle
While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.